URI RECEIVES $1.5 MILLION GRANT TO STUDY DISEASE PREVALENT IN ELDERLY POPULATION AND THOSE WITH ALZHEIMER'S DISEASE

KINGSTON, R.I., July 30 -- The University of Rhode Island issued the following news release:

KINGSTON, R.I. - July 30, 2026 - A $1.5M grant has been awarded to William Van Nostrand, co-executive director of the University of Rhode Island's George & Anne Ryan Institute for Neuroscience and professor of pharmaceutical and biomedical sciences in the URI College of Pharmacy, to study cerebralamyloid angiopathy (CAA), a disease prevalent in the elderly population and commonly found in patients with Alzheimer's disease.

CAA is characterized by the abnormal buildup of amyloid-beta protein in the walls of the brain's blood vessels. Over time, vascular amyloid accumulation can damage and ultimately weaken the vessels, increasing a person's risk fo...